Lessons learned from the development of imatinib

Nicholas B. Lydon, Brian J. Druker

Research output: Contribution to journalArticle

46 Scopus citations
Original languageEnglish (US)
Pages (from-to)S29-S38
JournalLeukemia Research
Volume28
Issue numberSUPPL. 1
DOIs
StatePublished - May 2004

Keywords

  • Bcr-Abl
  • CML
  • Drug design
  • Imatinib
  • STI 571
  • Tyrosine kinase

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this